Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Omnicell to Release Third Quarter 2018 Earnings Results on October 25, 2018 | ||||||||||||||||||||||||
By: PR Newswire Association LLC. - 18 Oct 2018 | Back to overview list |
|||||||||||||||||||||||
MOUNTAIN VIEW, Calif., Oct. 18, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 25, 2018, to discuss the Company's Third Quarter 2018 financial results.
About Omnicell Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers. Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,500 facilities worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. For more information about Omnicell, Inc. please visit www.omnicell.com. OMCL-E
View original content to download multimedia:http://www.prnewswire.com/news-releases/omnicell-to-release-third-quarter-2018-earnings-results-on-october-25-2018-300733963.html SOURCE Omnicell, Inc. |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |